Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-12 Sale | 2026-03-13 8:03 pm | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 7,239 | $17.02 | $123,208 | 1,765 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 8:05 pm | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 13,187 | $22.31 | $294,202 | 193,300 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-04 Tax Withholding | 2026-09-08 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 13,272 | $22.22 | 121,792 (Direct) | View |
| 2026-09-04 Tax Withholding | 2026-09-08 8:03 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 24,799 | $22.22 | 177,184 (Direct) | View |
| 2026-09-04 Tax Withholding | 2026-09-08 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 22,025 | $22.22 | 115,519 (Direct) | View |
| 2026-09-04 Tax Withholding | 2026-09-08 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 21,423 | $22.22 | 203,900 (Direct) | View |
| 2026-07-28 Option Award | 2026-07-29 8:05 pm | 2027-07-28 2036-07-28 | Sarepta Therapeutics Inc. | SRPT | SEVERINO MICHAEL Chief Executive Officer | 2,980,446 | $0 | 2,980,446 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:11 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 16,875 | $0 | 25,138 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:10 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 16,875 | $0 | 18,640 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:09 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 16,875 | $0 | 42,098 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:08 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 16,875 | $0 | 224,357 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:07 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Connelly Deirdre P Director | 16,875 | $0 | 22,100 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 16,875 | $0 | 48,407 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 16,875 | $0 | 504,027 (Direct) | View |
| 2026-06-04 Option Award | 2026-06-05 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 16,875 | $0 | 3,233,542 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 8:09 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 1,097 | $17.03 | 201,983 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 8:07 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 256 | $17.03 | 135,064 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 948 | $17.03 | 225,323 (Direct) | View |
| 2026-03-11 Tax Withholding | 2026-03-13 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 974 | $17.03 | 137,544 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:08 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 275 | $16.95 | 135,320 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:07 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 830 | $16.95 | 138,518 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 1,399 | $16.95 | 226,271 (Direct) | View |
| 2026-03-09 Tax Withholding | 2026-03-11 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 1,619 | $16.95 | 203,080 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:07 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 408 | $16.2 | 139,348 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 450 | $16.2 | 135,595 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 4,176 | $16.2 | 204,699 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 8,125 | $0 | 204,699 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 4,485 | $16.2 | 227,670 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 8,125 | $0 | 227,670 (Direct) | View |
| 2026-02-26 Exercise | 2026-03-02 08:00 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 7,450 | $13.71 | 200,750 (Direct) | View |
| 2026-02-26 Exercise | 2026-03-02 08:00 am | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 7,450 | $0 | 200,750 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-27 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Operating Officer | 1,875 | $0 | 8,125 (Direct) | View |
| 2026-02-25 Option Award | 2026-02-27 8:03 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 1,875 | $0 | 8,125 (Direct) | View |
| 2026-01-29 Tax Withholding | 2026-01-29 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 6,780 | $21.23 | 31,532 (Direct) | View |
| 2026-01-29 Exercise | 2026-01-29 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 10,500 | $13.71 | 31,532 (Direct) | View |
| 2026-01-29 Exercise | 2026-01-29 8:05 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 10,500 | $0 | 31,532 (Direct) | View |
| 2026-01-27 Exercise | 2026-01-29 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 10,500 | $13.71 | 207,482 (Direct) | View |
| 2026-01-27 Exercise | 2026-01-29 8:04 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 10,500 | $0 | 207,482 (Direct) | View |
| 2026-01-27 Tax Withholding | 2026-01-29 8:04 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 6,494 | $22.17 | 207,482 (Direct) | View |
| 2025-12-18 Option Award | 2025-12-19 4:40 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 20,000,000 | $0 | 20,000,000 (Indirect) | View |
| 2025-12-01 Tax Withholding | 2025-12-10 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 158 | $20.96 | 136,045 (Direct) | View |
| 2025-12-07 Option Award | 2025-12-09 8:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | INGRAM DOUGLAS S Chief Executive Officer | 489,084 | $0 | 929,391 (Direct) | View |
| 2025-11-28 Tax Withholding | 2025-12-02 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel | 229 | $21.12 | 139,756 (Direct) | View |
| 2025-11-17 Tax Withholding | 2025-11-19 8:05 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 4,582 | $18.42 | 224,030 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-05 9:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | 143,875 | $0 | 228,612 (Direct) | View |
| 2025-09-03 Option Award | 2025-09-05 9:30 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | 118,875 | $0 | 136,203 (Direct) | View |